Latest Update By Google
-
AstraZeneca Made $10 Billion Offer for Rhythm Pharmaceuticals - WSJ
November 4th 2026 10:28PM
The U.K. pharmaceutical giant offered to pay $124 a share for the biotech last month, the people sai...
-
HP Inc. Stock Rises After Pharma Heavyweight Named CEO - Barron's
November 4th 2026 9:51PM
Inc. shares were getting a lift on Wednesday after the company announced its new chief executive: Em...
-
Lenskart, Nykaa, Aurobindo Pharma shine; PI Industries, Apollo Tyres face margin heat
November 4th 2026 9:00PM
Wednesday's earnings rush kept investors busy, with Alembic Pharmaceuticals shares surging as mu...
-
Aurobindo Pharma Limited Q2 profit rises 32.5% on record revenue - Multibagg AI
November 4th 2026 8:16PM
Aurobindo Pharma reported record Q2 FY27 revenue of ₹10263 crore, while consolidated net profit ro...
-
Biotech turns on China while Big Pharma keeps shopping its pipeline: Signal Survey
November 4th 2026 7:27PM
Biotech pessimism about China more than doubles in Q3 BPSI, making it biopharma's No. 2 worry, w...
-
Latham Watkins Advises AbbVie on Global License Agreement With Nxera Pharma
November 4th 2026 7:01PM
Life Sciences Licensing team represents the global pharmaceutical company in the transaction involvi...
-
Alembic Pharma Q2 net profit rises 81%
November 4th 2026 5:48PM
Alembic Pharmaceuticals Limited reported its consolidated financial results for the second quarter a...
-
Decoded: Why India's $130 billion pharma ambition faces a hurdle as investigation ... - Mint
November 4th 2026 5:42PM
A Vector Consulting Group study finds that 80% of surveyed pharmaceutical manufacturing professional...
-
Pharma Industry Seeks Clarity on Batch-Wise Solvent Clearance, Flags Supply Disruption Risks
November 4th 2026 5:31PM
The pharmaceutical industry has sought clarity on the applicability of the Centre's new batch-wi...
-
Samsung Bio union vows strike as labor negotiations stall - Fierce Pharma
November 4th 2026 5:07PM
Samsung Biologics' labor union has another strike in the works after action planned for last mon...
-
Q2 Results Live Updates: Aurobindo Pharma Profit Increases 33%, NHPC Profit Rises 52 ...
November 4th 2026 5:05PM
Q2 Results Live Updates: Aurobindo Pharma Profit Increases 33%, NHPC Profit Rises 52%, Kansai Nerola...
-
India's Aurobindo Pharma's quarterly profit rises by a third on strong US demand | Reuters
November 4th 2026 4:59PM
Indian drugmaker Aurobindo Pharma reported a nearly 33% rise in second-quarter profit on Wedne...
-
Janhavi Shah appointed Marketing Manager at Evonile Pharma - Exchange4Media
November 4th 2026 4:51PM
Janhavi Shah has transitioned to Evonile Pharma as Marketing Manager, bringing her extensive experie...
-
Pharma Pulse: CVS Health to Break in Two, Bayer Weighs MFN
November 4th 2026 4:50PM
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast bringing you the latest insights shaping ...
-
Lenskart, Nykaa, Aurobindo Pharma shine; PI Industries, Apollo Tyres face margin heat | CNBC-TV18
November 4th 2026 4:44PM
AurobindoPharma and #ShippingCorporation reported strong year-on-year profit growth, while #NHPC and...
-
Q2 Results Today Highlights: BSE, Sundaram Finance, Dabur, Nykaa, Lenskart, Alembic ...
November 4th 2026 4:35PM
Aurobindo Pharma posts 32% Q2 net profit rise to ₹1,124 cr on 24% revenue growth to ₹10,263 cr, ...
-
Moberg Pharma receives US patent relating to an improved dosing regimen for MOB-015
November 4th 2026 4:31PM
Moberg Pharma AB, a Swedish pharmaceutical company, announced that the United States Patent and Trad...
-
Why pharma firms are going to Earth's orbit in search of new cancer drugs - The Guardian
November 4th 2026 4:30PM
For pharmaceutical companies, this could open up new ways of formulating medicines, as the size, sha...
-
Month in pharma news, explained – October 2026 - EMJ
November 4th 2026 4:28PM
Explore October's biggest pharma stories, from Regeneron's muscle-loss trial to Moderna'...
-
Q2 Results Today Highlights: BSE, Sundaram Finance, Dabur, Nykaa, Lenskart, Alembic ...
November 4th 2026 4:17PM
Emcure Pharma shares hit 10% upper circuit as Q2 net profit rises. Emcure Pharmaceuticals shares ral...